July 11, 2026 - 12:43

A groundbreaking clinical trial is offering new hope to people living with paralysis, with a technology that allows them to use their hands again. The experimental system uses a small implant placed directly on the brain's surface to read neural signals, which are then translated into commands that stimulate the muscles in the arm and hand.
Stephanie Still spoke with a patient participating in the study. The individual, who had been paralyzed for years, described the moment they were able to pick up a cup and drink without assistance for the first time since their injury. The patient noted that the sensation felt natural, as if the brain was simply remembering how to move the body.
The technology works by bypassing the damaged spinal cord. A computer chip decodes the person's intention to move, sending wireless signals to a sleeve worn on the forearm. This sleeve then delivers small electrical pulses to the muscles, causing them to contract in a coordinated sequence.
Researchers caution that the system is still in its early stages and is not a cure. The trial currently focuses on basic tasks like grasping objects and self-feeding. However, the results so far have been consistent, with several participants showing significant improvement in their ability to perform daily activities. The team hopes to expand the trial to include more patients and eventually refine the device for home use.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...